Syndecan-1 in Lung Repair
Syndecan-1 在肺修复中的应用
基本信息
- 批准号:8855470
- 负责人:
- 金额:$ 38.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-07 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AdhesivenessAffinityAsthmaBedsBindingBronchiectasisBronchiolitisCell LineCellsChronicChronic Obstructive Airway DiseaseCollagenCollagen Type IComplementComplexCore ProteinCouplingDataDiseaseEnvironmentEpithelialEpithelial CellsEpitheliumEventFibrosisFocal AdhesionsGenerationsGoalsGuanosine Triphosphate PhosphohydrolasesHealedHealthIn VitroInfectionInflammationInflammatoryInjuryIntegrin BindingIntegrinsKineticsLungMalignant NeoplasmsMapsMolecular ConformationNeoplasm MetastasisNeutrophil InfiltrationPTK2 genePathogenesisPathologicPathologyPeriodicityProcessProteinsPublishingRegulationRoleSignal TransductionSiteSpeedSurfaceTailTalinTherapeuticToxic Environmental SubstancesTractionTumor Cell InvasionWorkWound Healingcell motilityhealingin vivoin vivo Modelinjuredinterstitiallung repairmigrationpreventrepairedresponseresponse to injurysyndecanwound
项目摘要
DESCRIPTION (provided by applicant): The lungs are constantly exposed to environmental toxins. Injured lung epithelium must quickly heal in order to re-establish the barrier between the body and outside world. A number of remodeling diseases are the result of aberrant repair (e.g., asthma remodeling, COPD, obliterative bronchiolitis, bronchiectasis). Therefore understanding the normal reparative process in the lungs is fundamental to understanding the mechanisms of disease pathogenesis. After injury, epithelial cells migrate over the wounded surfaces by a coordinated response between the cell and matrix. The lung epithelium utilizes syndecan-1 in modulating the cell-matrix interaction. By functionally coupling itself to the a2�1 integrin, syndecan-1 tunes the cell adhesiveness to collagen thereby allowing efficient cell migration to occur. Preliminary data suggests that syndecan-1 is regulating the affinity state of the a2�1 integrin through a direct interaction of the ectodomain of these proteins. Additionally, changes in the integrin conformational state controls cell migration speed by altering focal adhesion dynamics. The goal of this proposal is to determine the mechanisms by which syndecan-1 regulates the activation state of the a2�1 integrin thereby modulating cell migration via changes to focal adhesion dynamics. These studies will be performed with cell lines, organotypic lung epithelial cultures and in vivo models of repair. Aim 1 will map the specific sequence of the syndecan-1 core protein needed to interact with the a2�1 integrin and identify additional binding partners in the syndecan-1 and a2�1 integrin complex. Aim 2 will focus on identifying mechanisms by which syndecan-1 regulates the 1221 integrin afinity state. Aim 3 will determine how syndecan-1 effects on a2�1 integrin afinity regulates focal adhesion dynamics and traction forces in migrating cells. These studies will better define the mechanisms by which syndecan-1 regulates cell migration through a2�1 integrin activation and potentially identify ways to manipulate this interaction to modulate lung repair.
描述(由申请人提供):肺部不断暴露于环境毒素中,受伤的肺上皮必须快速愈合,才能重新建立身体与外界之间的屏障,许多重塑疾病是异常修复的结果。因此,了解肺部的正常修复过程是了解疾病发病机制的基础。损伤后,上皮细胞通过细胞和基质之间的协调反应在受伤表面上迁移。肺上皮利用 syndecan-1 调节细胞-基质相互作用,通过功能性地将自身与 a2�1 整合素偶联,syndecan-1 进行调节。细胞对胶原的粘附性允许细胞发生迁移,因此初步数据表明 syndecan-1 通过有效的直接相互作用来调节 a2�1 整合素的亲和状态。此外,整合素构象状态的变化通过改变粘着斑动力学来控制细胞迁移速度,该提案的目的是确定 syndecan-1 调节 a2�1 整合素激活状态的机制。这些研究将通过细胞系、器官型肺上皮培养物和体内修复模型进行,目标 1 将绘制修复的具体序列。 syndecan-1 核心蛋白需要与 a2�1 整合素相互作用,并识别 syndecan-1 和 a2�1 整合素复合物中的其他结合伙伴。目标 2 将重点确定 syndecan-1 调节 1221 整合素亲和状态的机制。目标 3 将确定 syndecan-1 对 a2�1 整合素亲和力的影响如何调节迁移细胞中的粘着斑动力学和牵引力。将更好地定义 syndecan-1 通过 a2�1 整合素激活调节细胞迁移的机制,并可能确定操纵这种相互作用以调节肺修复的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER CHEN其他文献
PETER CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER CHEN', 18)}}的其他基金
Syndecan-1 suppression of lung inflammation
Syndecan-1 抑制肺部炎症
- 批准号:
10792072 - 财政年份:2022
- 资助金额:
$ 38.2万 - 项目类别:
Syndecan-1 suppression of lung inflammation
Syndecan-1 抑制肺部炎症
- 批准号:
10463119 - 财政年份:2022
- 资助金额:
$ 38.2万 - 项目类别:
Syndecan-1 suppression of lung inflammation
Syndecan-1 抑制肺部炎症
- 批准号:
10613558 - 财政年份:2022
- 资助金额:
$ 38.2万 - 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
- 批准号:
10654630 - 财政年份:2021
- 资助金额:
$ 38.2万 - 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
- 批准号:
10097806 - 财政年份:2021
- 资助金额:
$ 38.2万 - 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
- 批准号:
10452478 - 财政年份:2021
- 资助金额:
$ 38.2万 - 项目类别:
Syndecan-1 Regulations of Influenza Infection
Syndecan-1 流感感染调控
- 批准号:
8812061 - 财政年份:2014
- 资助金额:
$ 38.2万 - 项目类别:
Syndecan-1 Regulations of Influenza Infection
Syndecan-1 流感感染调控
- 批准号:
9198040 - 财政年份:2014
- 资助金额:
$ 38.2万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
Negative allosteric modulators for bradykinin B1 receptors
缓激肽 B1 受体的负变构调节剂
- 批准号:
10680762 - 财政年份:2023
- 资助金额:
$ 38.2万 - 项目类别:
Vagal airway sensory nerve activation by beta-coronavirus spike protein
β-冠状病毒刺突蛋白激活迷走神经气道感觉神经
- 批准号:
10748485 - 财政年份:2023
- 资助金额:
$ 38.2万 - 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 38.2万 - 项目类别:
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
- 批准号:
10600767 - 财政年份:2023
- 资助金额:
$ 38.2万 - 项目类别: